Resources
Learn more about our solutions and capabilities
The following resources provide more information on our technical capabilities and solutions for our therapeutic and basic research partners. Need additional information? Contact us to learn more.
Contact us5 Safety Risks for RNA Therapeutic Development
Review five safety risks and mitigation strategies in the development of RNA-based and RNA-targeting therapeutics.
Top 10 Data Problems for RNA Therapeutic Development
Consider the top data problems for RNA therapeutic development, from the lack of data to train AI models to the disconnect between RNA design metrics and therapeutic function.
What are siRNA off-targets?
Learn how siRNAs can silence unexpected genes and how to measure that off-target activity.
What are reactivity scores?
Learn how reactivity scores provide insights on RNA secondary structure.
What is the difference between IP and input?
Learn what IP and input libraries are and how they help drug developers identify protein and miRNA binding sites on RNA.
What are peaks?
Learn what peak calling and annotation are and how they help drug developers locate RBP binding sites and motifs.